查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233106

2023-2030 年按服務（醫學寫作與出版、醫學監測、醫學科學聯絡、醫學信息、其他）、按行業、按地區、細分趨勢劃分的醫療事務外包市場規模、份額、趨勢分析報告

Medical Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, Others), By Industry, By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫療事務外包市場的增長和趨勢

Grand View Research, Inc. 的最新報告預計，2023 年至 2030 年全球醫療事務外包市場規模將達到 46 億美元，複合年增長率為 13.6%。

醫學教育的轉型和治療罕見病的孤兒藥的興起是推動市場增長的主要因素。 製藥公司正在尋求幫助，以系統地定位這些療法在市場上的治療效果。 2021 年，美國食品藥品監督管理局 (FDA) 的藥物評價與研究中心 (CDER) 批准了 50 種新分子實體，其中一半以上 (26) 是孤兒藥。 預計在預測期內，越來越多的孤兒藥批准將推動全球醫療事務外包市場。

報銷方案的變化和價格壓力預計將增加製藥和醫療設備製造商採用成本削減措施的機會。 為此，印度和中國等國家有望推動醫療事務外包的離岸外包。 藥企將醫務服務外包，以獲得高質量的文檔，控制研發成本，降低醫務團隊建設的投資成本。 此外，製藥公司和醫療器械製造商將醫療事務外包，以劃分業務活動和管理產品生命週期。

此外，合同研究組織 (CRO) 正在通過提供具有成本效益的解決方案並遵守衛生當局的要求來推動市場增長。 在生物/製藥外包行業，由於 COVID-19 大流行，研發需求增加。 這種需求的增加，以及大流行的其他影響，例如對臨床試驗及其外包服務的需求增加，已導致一些 CRO 轉移和調整其業務重心。 大流行正在推動製藥行業發生積極變化，推動更多製藥公司和監管機構使用新技術進行遠程質量審核和測試。 此外，隨著數字化的發展，需要與患者群體互動並在專業護理中發揮作用的臨床試驗將成為醫療事務職能不可或缺的一部分，這有望減輕大流行的影響。

醫療事務外包市場報告亮點

  • 醫學寫作與出版領域將在 2022 年引領市場，並在預測期內實現強勁增長，因為預計市場對向醫療保健專業人員和患者傳達醫學信息的書面內容的需求不斷增長。
  • 由於許多製藥公司和醫療設備製造商的存在，到 2022 年，北美將以 34.9% 的份額主導全球市場。
  • 此外，醫療事務服務的高成本已成為一個主要挑戰，許多北美醫療設備製造商將功能外包給在該領域具有強大專業知識的離岸第三方供應商。我來到
  • 不過，由於 CRO 提供具有成本效益的服務，預計亞太地區在預測期內將以最快的複合年增長率增長。 亞太地區改進的監管框架和熟練勞動力的可用性也在推動市場增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 服務
    • 行業
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析（模型 1）
  • 次要信息列表
  • 主要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 細分市場展望

第 3 章醫療事務外包市場：變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 市場動態
    • 市場驅動因素分析
      • 增加臨床試驗的數量
      • CRO 提供具有成本效益的優質服務
      • 嚴格的監管場景
    • 市場製約因素分析
      • 無法聘請有經驗的技術人員
    • 行業問題
      • 關係管理
    • COVID-19 的影響
  • 醫療事務外包市場分析工具
    • 波特的五力分析
    • PESTEL 分析
    • 對主要交易和戰略聯盟的分析
      • 併購
      • 協作
      • 產品發布

第 4 章醫療事務外包市場：服務細分分析

  • 醫療事務外包：市場份額分析，2022 年和 2030 年
  • 醫學寫作和出版
  • 醫學監測
  • 醫學科學聯絡員 (MSL)
  • 醫療信息
  • 其他

第 5 章醫療事務外包市場：行業細分分析

  • 醫療事務外包：市場份額分析，2022 年和 2030 年
  • 醫藥
  • 生物製藥
  • 醫療設備
    • 治療性醫療設備
    • 診斷醫療設備

第 6 章醫療事務外包市場：區域分析

  • 醫療事務外包：市場份額分析，2022 年和 2030 年
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第七章公司簡介

  • 公司簡介
  • ICON plc
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • IQVIA
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • THE MEDICAL AFFAIRS COMPANY
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Syneos Health
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Thermo Fischer Scientific Inc.（PPD）
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Ashfield Healthcare
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • ZEINCRO Group
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Wuxi AppTec
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • SGS SA
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Indegene
    • 公司概況
    • 財務業績
    • 服務基準
    • 戰略舉措
Product Code: GVR-3-68038-891-6

Medical Affairs Outsourcing Market Growth & Trends:

The global medical affairs outsourcing market size is expected to reach USD 4.6 billion registering a CAGR of 13.6% from 2023 to 2030 according to a new report by Grand View Research, Inc. Transformation in the medical education and the rising number of orphan therapies for treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. During the year 2021, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 50 new molecular entities, of which more than half (26) were orphan drugs. A growing number of orphan drug approvals is expected to drive the global market for medical affairs outsourcing over the forecast period.

Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.

In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry. Also, digitalization has for clinical trials that requires interactions with patient groups, and role in specialty care are expected to become integral to the medical affairs function and reduce the impact of pandemic.

Medical Affairs Outsourcing market Report Highlights:

  • The medical writing & publishing segment led the market in 2022 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients.
  • North America dominated the global market with a share of 34.9% in 2022 owing to the presence of a large number of pharmaceutical and medical devices companies in the region.
  • Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain.
  • However, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region. In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Services
    • 1.1.2 Industry
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3
    • 1.10.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Medical Affairs Outsourcing Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing number of clinical trials
      • 3.2.1.2 Cost-effectiveness and high quality services offered by CROs
      • 3.2.1.3 Stringent regulatory scenario
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Inability to hire experienced technical staff
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Managing relationships
    • 3.2.4 COVID-19 Impact
  • 3.3 Medical Affairs Outsourcing Market Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTEL Analysis
    • 3.3.3 Major Deals & Strategic Alliances Analysis
      • 3.3.3.1 Mergers and Acquisitions
      • 3.3.3.2 Collaboration
      • 3.3.3.3 Product Launch

Chapter 4 Medical Affairs Outsourcing Market: Services Segment Analysis

  • 4.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
  • 4.2 Medical Writing & Publishing
    • 4.2.1 Medical writing & publishing market, 2018 - 2030 (USD Million)
  • 4.3 Medical Monitoring
    • 4.3.1 Medical monitoring market, 2018 - 2030 (USD Million)
  • 4.4 Medical Science Liaisons (MSLs)
    • 4.4.1 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
  • 4.5 Medical Information
    • 4.5.1 Medical information market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Medical Affairs Outsourcing Market: Industry Segment Analysis

  • 5.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
  • 5.2 Pharmaceutical
    • 5.2.1 Pharmaceutical market, 2018 - 2030 (USD Million)
  • 5.3 Biopharmaceutical
    • 5.3.1 Biopharmaceutical market, 2018 - 2030 (USD Million)
  • 5.4 Medical Devices
    • 5.4.1 Medical devices market, 2018 - 2030 (USD Million)
    • 5.4.2 Therapeutic Medical Devices
      • 5.4.2.1 Therapeutic medical devices market, 2018 - 2030 (USD Million)
    • 5.4.3 Diagnostic Medical Devices
      • 5.4.3.1 Diagnostic medical devices market, 2018 - 2030 (USD Million)

Chapter 6 Medical Affairs Outsourcing Market: Regional Analysis

  • 6.1 Medical Affairs Outsourcing: Market Share Analysis, 2022 & 2030
  • 6.2 North America
    • 6.2.1 North America medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.2 UK
      • 6.3.2.1 UK medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.5 Italy
      • 6.3.5.1 Italy medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Spain medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.7 Sweden
      • 6.3.7.1 Sweden medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.8 Denmark
      • 6.3.8.1 Denmark medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.9 Norway
      • 6.3.9.1 Norway medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 India medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Japan medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.5 Australia
      • 6.4.5.1 Australia medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.6 South Korea
      • 6.4.6.1 South Korea medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.7 Thailand
      • 6.4.7.1 Thailand medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.5 Kuwait
      • 6.6.5.1 Kuwait medical affairs outsourcing market, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Company Profiles
  • 7.2 ICON plc
    • 7.2.1 Company overview
    • 7.2.2 Financial performance
    • 7.2.3 Service benchmarking
    • 7.2.4 Strategic initiatives
  • 7.3 IQVIA
    • 7.3.1 Company overview
    • 7.3.2 Financial performance
    • 7.3.3 Service benchmarking
    • 7.3.4 Strategic initiatives
  • 7.4 THE MEDICAL AFFAIRS COMPANY
    • 7.4.1 Company overview
    • 7.4.2 Financial performance
    • 7.4.3 Service benchmarking
    • 7.4.4 Strategic initiatives
  • 7.5 Syneos Health
    • 7.5.1 Company overview
    • 7.5.2 Financial performance
    • 7.5.3 Service benchmarking
    • 7.5.4 Strategic initiatives
  • 7.6 Thermo Fischer Scientific Inc. (PPD)
    • 7.6.1 Company overview
    • 7.6.2 Financial performance
    • 7.6.3 Service benchmarking
    • 7.6.4 Strategic initiatives
  • 7.7 Ashfield Healthcare
    • 7.7.1 Company overview
    • 7.7.2 Financial performance
    • 7.7.3 Service benchmarking
    • 7.7.4 Strategic initiatives
  • 7.8 ZEINCRO Group
    • 7.8.1 Company overview
    • 7.8.2 Financial performance
    • 7.8.3 Service benchmarking
    • 7.8.4 Strategic initiatives
  • 7.9 Wuxi AppTec
    • 7.9.1 Company overview
    • 7.9.2 Financial performance
    • 7.9.3 Service benchmarking
    • 7.9.4 Strategic initiatives
  • 7.10 SGS SA
    • 7.10.1 Company overview
    • 7.10.2 Financial performance
    • 7.10.3 Service benchmarking
    • 7.10.4 Strategic initiatives
  • 7.11 Indegene
    • 7.11.1 Company overview
    • 7.11.2 Financial Performance
    • 7.11.3 Service benchmarking
    • 7.11.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Mergers & Acquisitions
  • Table 4 Collaboration
  • Table 5 Product launch

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Medical affairs outsourcing market snapshot (2022)
  • Fig. 10 Medical affairs outsourcing market segmentation
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Medical affairs outsourcing market services outlook: Segment dashboard
  • Fig. 19 Medical affairs outsourcing market: Services movement analysis
  • Fig. 20 Medical writing & publishing market, 2018 - 2030 (USD Million)
  • Fig. 21 Medical monitoring market, 2018 - 2030 (USD Million)
  • Fig. 22 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
  • Fig. 23 Medical information market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Medical affairs outsourcing market industry outlook: Segment dashboard
  • Fig. 26 Medical affairs outsourcing market: Industry movement analysis
  • Fig. 27 Pharmaceutical market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical market, 2018 - 2030 (USD Million)
  • Fig. 29 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Therapeutic medical devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Diagnostic medical devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional market: Key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 North America market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market, 2018 - 2030 (USD Million)
  • Fig. 38 UK market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market, 2018 - 2030 (USD Million)
  • Fig. 40 France market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 44 China market, 2018 - 2030 (USD Million)
  • Fig. 45 India market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 53 MEA market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market, 2018 - 2030 (USD Million)